A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma
BeiGene
BeiGene
Merck Sharp & Dohme LLC
Fudan University
The First Affiliated Hospital of Henan University of Science and Technology
Sichuan Cancer Hospital and Research Institute
Radiation Therapy Oncology Group
Fudan University
The First Affiliated Hospital of Henan University of Science and Technology
Federation Francophone de Cancerologie Digestive
Sichuan Cancer Hospital and Research Institute
Fudan University
The First Affiliated Hospital of Henan University of Science and Technology
Alliance for Clinical Trials in Oncology
The First Affiliated Hospital of Henan University of Science and Technology
The First Affiliated Hospital of Henan University of Science and Technology
National Cancer Institute (NCI)